• About us
  • Business
  • R&D+i
  • Sustainability
  • Investors
  • Talent
  • News
About us
  • About us

    We are a company dedicated to health, with national origin and global vocation.

  • Faes Farma Websites

    All the websites that make up our business lines.

  • Whistle-blower channel

    Internal information System (“Ethics Channel”).

Our purpose

Our mission, vision and values.

Our international presence

National pharmaceutical company with a global vocation.

Our history

We have been taking care of today and tomorrow for more than 90 years.

Our code of ethics

Our ethical principles are an integral part of our corporate culture.

Business
  • Business

    We are engaged in the research, development, manufacture and marketing of prescription medicines, healthcare and animal nutrition products.

  • Products

    A portfolio of premium Active Pharmaceutical Ingredients.

Direct commercialization

We market our own and third-party products.

Out-licensing

We license our own products.

CDMO

We help to develop successful projects.

In-licensing

Launching products from other laboratories.

R&D+i
  • R&D+i Strategy

    Our strategic focus on research for the development and innovation of new medicines.

  • Therapeutic areas

    We generate value for each of our therapeutic areas.

R&D+i News

Our progress in research, development and innovation.

Our clinical trials

We answer all frequently asked questions about clinical trials.

Business

Innovative and quality solutions with an integrated approach to health.

Sustainability

We guarantee integrity, transparency and commitment.

Sustainability
  • Commitment and SDGs

    Our commitment to sustainability and meeting the SDGs.

  • ESG Strategy

    Our strategy and sustainable performance in the past, present and future.

  • Environment

    Our measures to reduce the environmental impact of our activity.

  • Social

    Our commitment to society and to our employees.

  • Good governance

    Our commitment to integrate best practices in good governance.

Sustainability Policy

We manage responsibly, taking into account the concerns of our different stakeholders.

Statement of Non-Financial Information 2023

ESG Strategy

Find out more about our sustainability roadmap.

Whistle-blower channel

Internal information System (“Ethics Channel”).

Investors
  • Go to Investors

  • Corporate Governance

    Get to know the main governing bodies, the General Shareholders’ Meetings or the internal regulations.

  • Investor’s corner

    Space to consult the agenda, upcoming events and contact with the investor area of the company.

Capital Markets Day 2025 video

Capital Markets Day 2025 Presentation

Results 2024

Annual Report

Talent
News
  • Resources

    Access to the media library.

  • Press Contacts

    Contact our Communications Department.

  • Contact
  • Intranet
  • Professionals
  • EN
    • ES
  • About us
    About us
    • About us
    • Faes Farma Websites
    • Whistle-blower channel
  • Business
    Business
    • Business
    • Products
  • R&D+i
    R&D+i
    • R&D+i Strategy
    • Therapeutic areas
  • Sustainability
    Sustainability
    • Commitment and SDGs
    • ESG Strategy
    • Environment
    • Social
    • Good governance
  • Investors
    Investors
    • Go to Investors
    • Corporate Governance
    • Investor’s corner
  • Talent
    Talent

    Eu sed orci duis sit turpis. Vel sit commodo aliquam eget elementum enim.

  • News
    News

    The latest from Faes Farma.

    • Resources
    • Press Contacts
  • Contact
  • Intranet
  • Professionals
  • EN
    • ES

Clinical trials

Get to know our clinical trials:

 
BPAR: antihistaminic drug, parenteral route

BODT: oral antihistaminic drug, orodispersible tablet

BOFT: ophthalmic antihistamine

BKID: paediatric antihistaminic drug, oral route

CLEU: intestinal anti-inflammatory drug, oral route

CSUP: intestinal anti-inflammatory drug, rectal route

HIDR: 25-OH-D

WORF: 25-OH-D

HEMP: combination of corticosteroid and local anaesthetic drug

  • About us
    • About us
    • Faes Farma Websites
    • Whistle-blower channel
  • Business
    • Business
    • Products
  • R&D+i
    • R&D+i Strategy
    • Therapeutic areas
  • Sustainability
    • Commitment and SDGs
    • ESG Strategy
    • Environment
    • Social
    • Good governance
  • Investors
    • Go to Investors
    • Corporate Governance
    • Investor’s corner
  • Talent
  • News
    • Resources
    • Press Contacts
Code of Good Practices (Farmaindustria): TRANSPARENCY
Web Médica Acreditada. See more information
© FAES FARMA 2025
  • Legal disclaimer
  • Privacy policy
  • Cookie policy
  • Site Map
  • EN
    • ES
Cleantalk Pixel
Información sobre el aviso de cookies

Utilizamos cookies para brindarte la mejor experiencia en nuestro sitio web. Puedes aceptar todas las cookies pulsando el botón "Aceptar" o puedes obtener más información sobre las cookies que estamos utilizando, configurarlas o rechazar su uso pulsando en las preferencias

Cookies estrictamente necesarias Always active
Las cookies estrictamente necesarias tienen que activarse siempre para que podamos guardar tus preferencias de cookies
Preferencias
El almacenamiento o acceso técnico es necesario para la finalidad legítima de almacenar preferencias no solicitadas por el abonado o usuario.
Cookies de terceros
El almacenamiento o acceso técnico que es utilizado exclusivamente con fines estadísticos. Esta web utiliza Google Analytics para recopilar información anónima tal como el número de visitantes del sitio, o las páginas más populares.
Marketing
El almacenamiento o acceso técnico es necesario para crear perfiles de usuario para enviar publicidad, o para rastrear al usuario en una web o en varias web con fines de marketing similares.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
Configurar preferencias
{title} {title} {title}